Reblozyl 75 mg (Luspatercept POWDER FOR SOLUTION) 75 MG

REBLOZYL 75 MG is a powder for solution containing luspatercept, used for managing certain blood disorders. This subcutaneous medication supports erythropoiesis, the process of red blood cell production.

Strength

75 MG

Manufacturer / TM Owner

BRISTOL-MYERS SQUIBB CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REBLOZYL 75 MG is primarily used to treat anemia in adults with specific blood disorders. It works by stimulating the production of red blood cells, which can help alleviate symptoms associated with low hemoglobin levels. This medication is often prescribed for conditions where the body's natural red blood cell production is impaired.

Side Effects

Common effects of REBLOZYL 75 MG may include injection site reactions, such as redness or swelling. Some individuals might experience fatigue, joint pain, or headaches. These effects vary and are not experienced by everyone using the medication.

Precautions & Warnings

REBLOZYL 75 MG should be handled with care, ensuring proper storage and administration. It is important to follow the healthcare provider's instructions for preparation and use. Always inform your healthcare provider about any existing medical conditions or allergies before starting this treatment.

Avoid Interactions

REBLOZYL 75 MG may interact with other medications, including those that affect blood cell production or the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this medication.

Frequently Asked Questions

REBLOZYL 75 MG is used to manage anemia in adults with certain blood disorders by stimulating red blood cell production.

REBLOZYL 75 MG is administered subcutaneously as a solution prepared from the powder.

Common side effects may include injection site reactions, fatigue, joint pain, and headaches.

It is important to consult a healthcare provider before combining REBLOZYL 75 MG with other medications to avoid potential interactions.

REBLOZYL 75 MG should be stored as per the instructions provided by the manufacturer to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.